Works matching DE "SHANGHAI Fosun Pharmaceutical (Group) Co. Ltd."

Chindex to Be Acquired by Fosun Pharma and TPG Capital for $369 Million.

Published in:

China Business Review, 2014, p. 4

Publication type:

Article